Catalyst Pharmaceuticals, Inc.CPRXNASDAQ
LOADING
|||
EBITDA Over Time
Trending higher, above historical average.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$232.90M
↑ 376% above average
Average (9y)
$48.93M
Historical baseline
Range
High:$232.90M
Low:$-35.26M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $232.90M | +94.6% |
| 2023 | $119.69M | +16.1% |
| 2022 | $103.08M | +96.0% |
| 2021 | $52.58M | +27.0% |
| 2020 | $41.40M | +29.9% |
| 2019 | $31.88M | +190.4% |
| 2018 | $-35.26M | -90.7% |
| 2017 | $-18.49M | -2.6% |
| 2016 | $-18.03M | +11.9% |
| 2015 | $-20.46M | - |